STAAR Surgical Company (STAA): Company Short-Term Debts

Public company logo of STAAR Surgical Co (STAA)

STAAR Surgical Company (STAA) is pursuing global growth by expanding its presence in the Americas while maintaining dominance in Asia. The company generates revenue through the sale of high-tech ophthalmological lenses designed to combat astigmatism and myopia. Market valuation dynamics on GURU.Markets captured a figure of 0.00, while the business minimizes external dependencies by synthesizing Collamer biomaterials in-house at its own facilities.

STAA (STAAR Surgical) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

Analytical breakdowns for STAAR Surgical Co (STAA)

- stock price and consensus target price:
Stock Price STAAR Surgical|STAA - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization STAAR Surgical Company|STAA - Real Price to Acquire Entire Company
- business book valuation details:
Book Value per Share STAAR Surgical|STAA - Book Capitalization|Market Value to Book Value Ratio staar.com|STAA - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio STAAR Surgical Company|STAA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital STAAR Surgical Company|STAA - Company Total Debt Obligations|Debt to Book Capitalization Ratio STAAR Surgical Company|STAA - Company Long-Term Indebtedness|Company Short-Term Debt STAAR Surgical|Quick Liquidity Indicator staar.com
- net income and valuation multiples indicators:
STAA - Profit After Payment of Taxes
Fundamental company analysis:STAA - STAAR Surgical
Flagship merchandise of STAAR Surgical Co

Short-term debt reflects the total obligations of the issuer with a maturity of up to one year. By analyzing the level of short-term liabilities, an investor assesses the current liquidity and solvency of the business. This metric is calculated as the sum of all current borrowings and interest payments. For STAAR Surgical Company (STAA), this serves as an indicator of financial stability when procuring biocompatible materials. Optimizing these costs confirms the efficiency of managing production expenses and resources.

Direct competitors

Intuitive - Company Short-Term Debts|Short-Term Debt Volume Danaher Corporation DHR|BDX: Company Short-Term Debts|Company Current Liabilities STERIS Group|WST (West Pharmaceutical Services) - Company Short-Term Debts|Company Short-Term Debts baxter.com|Company Short-Term Debt Masimo (MASI)|Company Short-Term Debt STVN (Stevanato Group SpA)|Teleflex Inc - Company Current Liabilities|Company Short-Term Loans and Borrowings MMSI|Envista Holdings - Company Short-Term Debts|Short-Term Debt Volume icumed.com ICUI|Dentsply Sirona (XRAY) - Company Short-Term Debt|Company Short-Term Indebtedness LMAT|Company Short-Term Debt AtriCure Corp|niagenbioscience.com (NAGE) - Short-Term Debt Volume|Company Current Liabilities ZIMV (ZimVie Inc.)|Amount of Current Liabilities ANGO|Company Short-Term Debt Cerus CERS|Company Short-Term Loans and Borrowings TKNO|MGRM: Company Current Liabilities|STSS - Company Short-Term Debts|infusystem.com (INFU) - Company Short-Term Debt|Company Current Liabilities utahmed.com|KRMD (KORU Medical Systems, Inc.) - Company Short-Term Debts|Short-Term Debt Nyxoah SA NYXH|Company Short-Term Debt Microbot Medical Inc (MBOT)|Pro-Dex Inc. - Company Short-Term Indebtedness|Zentek Ltd. - Company Current Liabilities|Amount of Current Liabilities ELUT (elutia.com)|MLSS - Company Short-Term Debt|Short-Term Debt Volume NEXGEL Inc. NXGL|retractable.com (RVP) - Company Short-Term Debt|HBIO - Short-Term Debt Volume|Company Current Liabilities FEMY|MHUA (Meihua Medical) - Amount of Current Liabilities|Company Short-Term Debts POAI|Company Short-Term Debts callanjmb.com (CJMB)|Company Short-Term Debts ATRI (Atrion Corp)|Company Short-Term Debts NeuroMetrix Corporation NURO